Organization
Cardiosurgery Dept.
1 abstract
Abstract
ANTIBODY TO ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) LEVEL DETERMINES CLINICAL RESPONSE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) TO DMARD THERAPYOrg: Laboratory for Fundamental Research, Cardiosurgery Dept., Institute of Urgent and Recovery Surgery, Donetsk, Ukraine, Chair of Family Medicine, Immunology Dept,